Nova Patents
AT390142T

A synergistic composition for the treatment of diabetes mellitus

Abstract

The present invention is a required synergy composite for diabetes disposal of diabetic disposal for patients (subject), トリゴネリン (Trigonelline) of the concentration of 20*30% of range, the amino acid of the concentration of 20*60% of range, and the soluble fiber of the concentration of 10*60% of range with the additive which can be permitted arbitrarily and in medicine, It is related with the composite to contain, its manufacturing process, and the diabetic disposal method.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

21 members in 7 offices

This recordMember, by publication datePriority claim

Priority claims4

Priority claims
DocumentOfficeKindDate
47074203United States of AmericaP
47074203United States of AmericaP
470742P–––
US20030470742P–––

Members21

Family members, oldest first
DocumentOfficeKind
WO2004100968A2World Intellectual Property Organization (WIPO)A2
US2005008716A1United States of AmericaA1
WO2004100968A3World Intellectual Property Organization (WIPO)A3
EP1638586A2European Patent Office (EPO)A2
US2006134242A1United States of AmericaA1
US2006153937A1United States of AmericaA1
US7141254B2United States of AmericaB2
JP2006528235AJapanA
US2006292252A1United States of AmericaA1
US2007031521A1United States of AmericaA1
EP1638586B1European Patent Office (EPO)B1
AT390142TThis recordAustriaT
ATE390142T1AustriaT1
DE602004012745D1GermanyD1
DK1638586T3DenmarkT3
DE602004012745T2GermanyT2
JP4353982B2JapanB2
US7641925B2United States of AmericaB2
US7674485B2United States of AmericaB2
US7674486B2United States of AmericaB2
US7736676B2United States of AmericaB2